RMD.AX - ResMed Inc.

ASX - ASX Delayed Price. Currency in AUD
13.60
-0.57 (-4.02%)
At close: 4:10PM AEST
Stock chart is not supported by your current browser
Previous Close14.17
Open13.83
Bid13.59 x 0
Ask13.60 x 0
Day's Range13.56 - 13.83
52 Week Range12.51 - 16.57
Volume2,264,010
Avg. Volume2,331,534
Market Cap20.028B
Beta (3Y Monthly)0.70
PE Ratio (TTM)43.60
EPS (TTM)0.31
Earnings DateN/A
Forward Dividend & Yield0.18 (1.28%)
Ex-Dividend Date2018-05-09
1y Target Est12.43
  • Business Wire11 days ago

    ResMed to Report Third Quarter Fiscal 2019 Earnings on May 2, 2019

    ResMed today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes.

  • ResMed Introduces AirFit P30i, Its First Top-of-Head-Connected Nasal Pillows CPAP Mask
    Business Wire11 days ago

    ResMed Introduces AirFit P30i, Its First Top-of-Head-Connected Nasal Pillows CPAP Mask

    Now offers “tube-up” design options for nasal and nasal pillows mask wearers, providing even more flexibility and choice to help users sleep better in any position

  • Business Wire12 days ago

    Brightree ReSupply Solution Expands Beyond Sleep to 3 More Disease Segments

    - Solution expands to incontinence, diabetic, and enteral segments

  • Business Wire18 days ago

    Brightree Introduces First-of-its-kind Analytics Suite for HMEs

    HMEs can now see workflow insights, KPI tracking, and peer benchmarking on one auto-produced dashboard to enhance business decision-making

  • Were Hedge Funds Right About Souring On ResMed Inc. (RMD)?
    Insider Monkey22 days ago

    Were Hedge Funds Right About Souring On ResMed Inc. (RMD)?

    Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ a complex analysis to determine the best stocks to invest in. A particularly […]

  • GlobeNewswire26 days ago

    Investor Expectations to Drive Momentum within United Technologies, Third Point Reinsurance, Consolidated Communications, Covanta Holding, Modine Manufacturing, and ResMed — Discovering Underlying Factors of Influence

    NEW YORK, March 27, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Business Wire28 days ago

    ResMed Launches Next-generation ReSupply Solution

    Brand-agnostic solution helps HMEs provide timely PAP replacement supplies to sleep apnea patients, increases long-term adherence and improves satisfaction

  • Business Wirelast month

    ResMed to Host an Investor Meeting on April 4, 2019

    ResMed (RMD) (RMD.AX) today announced it will host an investor meeting on Thursday, April 4th to discuss the Company’s recent acquisitions, existing joint ventures and strategy pertaining to respiratory care and out-of-hospital software. Additional information regarding the investor meeting, including the specific time and webcast link for the presentations, will be made available approximately one week prior to the event and may be accessed by visiting http://investor.resmed.com. Presentations at the investor meeting will be transmitted by a live webcast, which may be accessed by visiting http://investor.resmed.com.

  • Markitlast month

    See what the IHS Markit Score report has to say about ResMed Inc.

    ResMed Inc NYSE:RMDView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for RMD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold RMD had net inflows of $5.37 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire2 months ago

    ResMed Acquires HB Healthcare to Help Millions of Koreans Living with Sleep Apnea, Other Respiratory Conditions

    ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions. HBH, a fast-growing privately owned South Korean home medical equipment provider, serves both reimbursed and cash-pay customers of sleep and respiratory care devices.

  • Business Wire2 months ago

    Brightree Announces Enhanced Pharmacy Suite

    - Home infusion therapy providers and HME pharmacies benefit from feature-rich functionality within a single software solution for all clinical, billing and reporting needs

  • GlobeNewswire2 months ago

    Factors of Influence in 2019, Key Indicators and Opportunity within Franklin Resources, Heartland Express, Ameriprise Financial, Merck & Co., NGL Energy Partners LP, and ResMed — New Research Emphasizes Economic Growth

    NEW YORK, Feb. 28, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • GlobeNewswire2 months ago

    MatrixCare Signs National Agreement with PharMerica for NCPDP Bidirectional and Pharmacy-Centric Order Integration

    BLOOMINGTON, Minn., Feb. 27, 2019 -- MatrixCare announced today that it has entered into a National Pharmacy Integration and Electronic Medication Administration Record (eMAR).

  • 84% of people with asthma may be using their inhalers incorrectly, Propeller Health study finds
    PR Newswire2 months ago

    84% of people with asthma may be using their inhalers incorrectly, Propeller Health study finds

    MADISON, Wis., Feb. 21, 2019 /PRNewswire/ -- The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology: In practice by digital therapeutics company Propeller Health, in partnership with the University of Colorado School of Medicine and Children's Hospital Colorado. Many asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose.

  • Reuters2 months ago

    Fisher & Paykel, ResMed settle global patent disputes; shares jump

    New Zealand medical device maker Fisher & Paykel Healthcare Corp Ltd and U.S. rival ResMed Inc have agreed to settle patent infringement disputes, ending a three-year tussle that spanned the globe and cost each side millions of dollars in legal fees. In a joint statement on Thursday, the companies agreed to end all ongoing infringement cases and said neither would admit liability or make any payment. Fisher & Paykel shares were 6.9 percent higher after the announcement, reaching a more than four-month peak, whereas ResMed's Australian depository receipts were 1.1 percent firmer.

  • Reuters2 months ago

    NZ's Fisher & Paykel and ResMed settle global patent disputes

    Medical device maker Fisher & Paykel Healthcare and U.S.-based ResMed on Thursday agreed to settle disputes over patent infringement, bringing to an end a tussle spanning the globe. The two companies had ...

  • ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
    Business Wire2 months ago

    ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation

    ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venues around the world. The settlement involves no payment or admission of liability by either side. “I am pleased we were able to resolve these disputes,” said ResMed CEO Mick Farrell.

  • GlobeNewswire3 months ago

    A New Era in Healthcare with Digital Health: Innovest Global Inc. (OTC: IVST), eWellness Healthcare, ResMed Inc. and Progressive Care Inc.

    Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how healthcare is changing in the digital age. Investorideas recently reported on how Digital Health technologies enabling out-of-hospital care and monitoring are forecast to grow by 30 percent and cross the $25 billion mark. In the article, Kamaljit Behera, Industry Analyst, Transformational Health, said, "In this highly digitized environment, artificial intelligence (AI) will permeate the life sciences ecosystem, and its use in healthcare IT (HIT) is likely to cross $1.7 billion by the end of 2019.

  • ResMed (RMD) Q2 2019 Earnings Conference Call Transcript
    Motley Fool3 months ago

    ResMed (RMD) Q2 2019 Earnings Conference Call Transcript

    RMD earnings call for the period ending December 31, 2018.

  • Barrons.com3 months ago

    The Dow Rises 184 Points Because the Fed Trumps the End of the Shutdown

    The Dow Jones Industrial Average rose 0.8% to close at 24,737.20 on a report that the Fed might stop winding down its bond holdings earlier than expected.

  • GuruFocus.com3 months ago

    3 Stocks Move Friday

    ResMed, Intuitive Surgical fall, OSI Systems rises

  • Associated Press3 months ago

    Western Digital, Starbucks rise while AbbVie, Intel drop

    Stocks that moved substantially or traded heavily Friday: Western Digital Corp., up $3.02 to $43.16 The hard-drive maker reported better-than-expected quarterly financial results and an upbeat forecast. ...

  • TheStreet.com3 months ago

    ResMed Tanks on Second-Quarter Revenue Miss

    The San Diego company reported a 9% increase in adjusted revenue to $651.1 million but lagged Wall Street's expectations of $667 million. "We had a solid quarter with top-line growth and gross margin expansion, as well as continued fiscal discipline to drive leverage and improved operating profit," said Mick Farrell, ResMed's CEO. Through the first half of the company's fiscal year, ResMed has posted an increase of 11% on adjusted revenue while earnings have gained 9%.

  • Acquisitions Cause ResMed's Profit Growth to Stall
    Motley Fool3 months ago

    Acquisitions Cause ResMed's Profit Growth to Stall

    Lavish spending on additions to the company's growing software business took a toll on net income.

  • Why ResMed Is Plunging Today
    Motley Fool3 months ago

    Why ResMed Is Plunging Today

    Disappointing quarterly results took a toll on the medical-device stock.